|
SWIM
Latham Group, Inc.
SWIM · Q4 FY2021
|
Q4 FY2021 |
|
SWIM Q4 FY2021 transcript
|
|
LFST
LifeStance Health Group, Inc.
LFST · Q4 FY2021
|
Q4 FY2021 |
|
LFST Q4 FY2021 transcript
|
|
FEIM
Frequency Electronics Inc
FEIM · Q3 FY2022
|
Q3 FY2022 |
|
FEIM Q3 FY2022 transcript
|
|
ZUMZ
Zumiez Inc
ZUMZ · Q4 FY2022
|
Q4 FY2022 |
|
ZUMZ Q4 FY2022 transcript
|
|
SMSI
Smith Micro Software, Inc.
SMSI · Q4 FY2021
|
Q4 FY2021 |
|
SMSI Q4 FY2021 transcript
|
|
GNE
Genie Energy Ltd.
GNE · Q4 FY2021
|
Q4 FY2021 |
|
GNE Q4 FY2021 transcript
|
|
XERS
Xeris Biopharma Holdings, Inc.
XERS · Q4 FY2021
|
Q4 FY2021 |
|
XERS Q4 FY2021 transcript
|
|
AFCG
Advanced Flower Capital Inc.
AFCG · Q4 FY2021
|
Q4 FY2021 |
|
AFCG Q4 FY2021 transcript
|
|
LZ
Legalzoom.Com, Inc.
LZ · Q4 FY2021
|
Q4 FY2021 |
|
LZ Q4 FY2021 transcript
|
|
SEAT
Vivid Seats Inc.
SEAT · Q4 FY2021
|
Q4 FY2021 |
|
SEAT Q4 FY2021 transcript
|
|
LMNR
Limoneira CO
LMNR · Q1 FY2022
|
Q1 FY2022 |
|
LMNR Q1 FY2022 transcript
|
|
ORCL
Oracle Corp
ORCL · Q3 FY2022
|
Q3 FY2022 |
|
ORCL Q3 FY2022 transcript
|
|
LCTX
Lineage Cell Therapeutics, Inc.
LCTX · Q4 FY2021
|
Q4 FY2021 |
|
LCTX Q4 FY2021 transcript
|
|
CRVS
Corvus Pharmaceuticals, Inc.
CRVS · Q4 FY2021
|
Q4 FY2021 |
|
CRVS Q4 FY2021 transcript
|
|
DXYN
Dixie Group Inc
DXYN · Q4 FY2021
|
Q4 FY2021 |
|
DXYN Q4 FY2021 transcript
|
|
TXMD
TherapeuticsMD, Inc.
TXMD · Q4 FY2021
|
Q4 FY2021 |
|
TXMD Q4 FY2021 transcript
|
|
HIPO
Hippo Holdings Inc.
HIPO · Q4 FY2021
|
Q4 FY2021 |
|
HIPO Q4 FY2021 transcript
|
|
ULTA
Ulta Beauty, Inc.
ULTA · Q4 FY2022
|
Q4 FY2022 |
|
ULTA Q4 FY2022 transcript
|
|
GNLN
Greenlane Holdings, Inc.
GNLN · Q4 FY2021
|
Q4 FY2021 |
|
GNLN Q4 FY2021 transcript
|
|
GCO
Genesco Inc
GCO · Q4 FY2022
|
Q4 FY2022 |
|
GCO Q4 FY2022 transcript
|
|
ACHV
Achieve Life Sciences, Inc.
ACHV · Q4 FY2021
|
Q4 FY2021 |
|
ACHV Q4 FY2021 transcript
|
|
NNBR
Nn Inc
NNBR · Q4 FY2021
|
Q4 FY2021 |
|
NNBR Q4 FY2021 transcript
|
|
LTRN
Lantern Pharma Inc.
LTRN · Q4 FY2021
|
Q4 FY2021 |
|
LTRN Q4 FY2021 transcript
|
|
VRDN
Viridian Therapeutics, Inc.\DE
VRDN · Q4 FY2021
|
Q4 FY2021 |
|
VRDN Q4 FY2021 transcript
|